Microbiome mediated toxicity of drugs and environmental pollutants

The bacteria living in a person's gut can chemically alter medications, sometimes making them less effective or producing harmful side effects. This matters because current drug safety testing largely ignores the gut microbiome's role. The same bacteria that help digest food can also transform drugs and environmental chemicals like pesticides into different compounds—sometimes toxic, sometimes benign. Researchers do not yet understand the molecular details of these interactions, which means drug development and safety regulation operate with a significant blind spot. This programme aims to map exactly how gut bacteria interact with a wide range of chemicals, from prescription drugs to environmental pollutants. If successful, it could produce predictive models that help pharmaceutical companies design safer drugs and consumer products from the start. It could also reduce the need for animal testing by providing a more accurate, human-relevant way to assess chemical toxicity. Regulators could use these models to set safer exposure limits for pesticides and industrial chemicals, protecting both human health and the environment.